The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
Abstract
OBJECTIVE: Recent studies suggest the beneficial effects of metformin on glucose metabolism may be microbially mediated. We examined the association of type 2 diabetes, metformin, and gut microbiota in community-dwelling Colombian adults. On the basis of previous research, we hypothesized that metformin is associated with higher levels of short-chain fatty acid (SCFA)–producing and mucin-degrading microbiota. RESEARCH DESIGN AND METHODS: Participants were selected from a larger cohort of 459 participants. The present analyses focus on the 28 participants diagnosed with diabetes—14 taking metformin— and the 84 participants without diabetes who were matched (3-to-1) to participants with diabetes by sex, age, and BMI. We measured demographic information, anthropometry, and blood biochemical parameters and collected fecal samples from which we performed 16S rRNA gene sequencing to analyze the composition and structure of the gut microbiota. RESULTS: We found an association between diabetes and gut microbiota that was modified by metformin use. Compared with participants without diabetes, participants with diabetes taking metformin had higher relative abundance of Akkermansia muciniphila, a microbiota known for mucin degradation, and several gut microbiota known for production of SCFAs, including Butyrivibrio, Bifidobacterium bifidum, Megasphaera, and an operational taxonomic unit of Prevotella. In contrast, compared with participants without diabetes, participants with diabetes not taking metformin had higher relative abundance of Clostridiaceae 02d06 and a distinct operational taxonomic unit of Prevotella and a lower abundance of Enterococcus casseliflavus. CONCLUSIONS: Our results support the hypothesis that metformin shifts gut microbiota composition through the enrichment of mucin-degrading A. muciniphila as well as several SCFA-producing microbiota. Future studies are needed to determine if these shifts mediate metformin’s glycemic and anti-inflammatory properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biguanides/metformin, the first-line therapeutics for T2D, modifies microbiota leading to an increase in A. muciniphila, as well as several SCFA-producing microbiota, favoring an improvement on mucin-producing goblet cells, pro-inflammatory IL-6, and glucose tolerance [304].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [304]
In the citing paper
“In human diabetic individuals, metformin was shown to shift gut microbiota composition to predominantly short-chain fatty-acid producing microbes”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as de la Cuesta-Zuluaga et al. 2017
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 2×
“pairwise tests among groups of participants using the unpaired Wilcoxon rank sum test, and finally uses LDA to estimate the effect size of each differentially abundant OTU (24).”
MethodKozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“Prevotella has been associated with carbohydrate-baseddiets anddegradation of complex polysaccharides (26), whereas E.”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 3×
“abundance of Akkermansia muciniphila (11–13), a mucin-degrading bacteria that has been shown to reverse metabolic disorders (1,12).”
BackgroundInfluentialGut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851 · cited 1×
“through effects on bile acid secretion (31).”
Cited by
Items 401–500 of 731
Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
Chu, N. H. S., Chan, J. C. N., & Chow, E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857090 · Cited by 21
“In animal studies, GLP-1 receptor agonists reduced hyperglycaemia which was associated with a reduced abundance of Romboutsia and Ruminiclostridium as well as an increased abundance of Prevotella was associated with reduction of body weight (53).”
BackgroundResultInfluentialGut Microbiota Characteristics Are Associated With Severity of Acute Radiation-Induced Esophagitis
Lin, M.-Q., Wu, Y., Yang, J., Lin, H., Liu, L., Yu, Y., Yao, Q., & Li, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.883650 · Cited by 19
Elbere, I., Orlovskis, Z., Ansone, L., Silamiķelis, I., Jagare, L., Birzniece, L., Megnis, K., Leškovskis, K., Vaska, A., Turks, M., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2361491 · Cited by 19
Metformin in gestational diabetes: physiological actions and clinical applications
Mason, T., Alesi, S., Fernando, M., Vanky, E., Teede, H. J., & Mousa, A. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01049-w · Cited by 20
“Such alterations in gut microbiota composition contribute to enhanced production of shortchain fatty acids such as acetate, butyrate and propionate via the fermentation of dietary fibres 47,50,51 .”
Olotu, T., & Ferrell, J. M. (2024) · Microorganisms · doi:10.3390/microorganisms12122488 · Cited by 18
“Patients with MASH have elevated levels of TBA, both in liver tissue and plasma, suggesting a relationship between toxic levels of BA and the development of MASH [80].”
New Horizons in Microbiota and Metabolic Health Research
Mishra, S. P., Jain, S., Taraphder, S., & Yadav, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa769 · Cited by 19
Modulation effects of Dendrobium officinale on gut microbiota of type 2 diabetes model mice
Wang, S., Li, X., & Shen, L. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab020 · Cited by 22
Yan, S., Chen, L., Li, N., Wei, X., Wang, J., Dong, W., Wang, Y., Shi, J., Ding, X., & Peng, Y. (2024) · Bioresources and Bioprocessing · doi:10.1186/s40643-024-00766-4 · Cited by 19
Chen, Q., Cheng, W., Zhang, J., Chi, C., Lin, M., He, C., Liao, Z., & Gong, F. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.017 · Cited by 19
Akkermansia muciniphila: A Potential Target for the Prevention of Diabetes
He, K., An, F., Zhang, H., Yan, D., Li, T., Wu, J., & Wu, R. (2024) · Foods · doi:10.3390/foods14010023 · Cited by 22
Lee, J. H. J., & Zhu, J. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220979952 · Cited by 18
“Akkermansia municiphila (Phylum Verrucomicrobia), a mucin-degrading bacteria, is also described as SCFA-producing (such as propionate and acetate).(75,76) Firmicutes and Bacteroidetes are the major population in healthy gut microbiota.”
BackgroundYoung at Gut—Turning Back the Clock with the Gut Microbiome
Narasimhan, H., Ren, C. C., Deshpande, S., & Sylvia, K. E. (2021) · Microorganisms · doi:10.3390/microorganisms9030555 · Cited by 17
Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
Kononova, Y. A., Likhonosov, N. P., & Babenko, A. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042363 · Cited by 18
Metformin Influence on the Intestinal Microbiota and Organism of Rats with Metabolic Syndrome
Ермоленко, Е. И., Симаненкова, А. В., Alferova, L. S., Lavrenova, N. S., Kotyleva, M., Минасян, С. М., Chernikova, A. T., Тимкина, Н. В., Сергеевич, Г. Н., Dmitriev, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126837 · Cited by 18
“The microbiota in DM2 is the most well studied (described in scientific literature).”
BackgroundInfluentialZhang, B., Jin, Z., Zhai, T., Ding, Q., Yang, H., Wang, J., Zhang, L., & Zhao, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1011050 · Cited by 19
Role of gut microbiota in the development of non-alcoholic fatty liver disease
Wang, X., Xia, J., & Jiang, C. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.006 · Cited by 17
Use of the microbiome in the management of children with type 2 diabetes mellitus
Brar, P. C., & Kohn, B. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000781 · Cited by 17
Cravalho, C. K. L., Meyers, A. G., Mabundo, L. S., Courville, A. B., Yang, S. B., Cai, H., Dai, Y., Walter, M. F., Walter, P. J., Sharma, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05236-y · Cited by 18
“Metformin may directly inhibit dipeptidyl peptidase IV and GLP-1 catabolism [28], or indirectly stimulate enteroendocrine GLP-1 secretion via increasing the populations of short chain fatty acid-producing bacteria [9, 29, 30].”
BackgroundYao, Q., Zhang, W., Wang, Y., Shi, L., Zhao, Y., Liang, J., Zhao, Y. P., Kang, J., Zheng, X., Guo, R., et al. (2025) · Nutrients · doi:10.3390/nu17101670 · Cited by 16
Drugs Versus Microbiota: How Pharmacotherapy Affects Gut and Probiotic Bacteria
Zawistowska-Rojek, A., & Tyski, S. S. (2025) · Pharmaceuticals · doi:10.3390/ph18091372 · Cited by 17
Gut Microbiota: An Ally in the Mechanisms and Interventions of Healthy Aging
Chatterjee, S. S., Hebbani, A. V., & Syed, K. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7040068 · Cited by 17
New insights into the links between anti-diabetes drugs and gut microbiota
Hu, R., Yuan, Y., Liu, C., Zhou, J., Ji, L., & Jiang, G. (2020) · Endocrine Connections · doi:10.1530/ec-20-0431 · Cited by 17
Yao, L., Wang, Y., Qin, S., Zhu, S., & Wu, L. (2023) · Communications Biology · doi:10.1038/s42003-023-04475-0 · Cited by 16
Cabello-Olmo, M., Oneca, M., Urtasun, R., Pajares, M. J., Goñi, S., Riezu‐Boj, J. I., Milagro, F. I., Ayo, J., Encío, I., Barajas, M. A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041203 · Cited by 17
“Regarding the relative abundance found in the study, the rise in Akkermansia with metformin (alone or combined with pA1c) is in good agreement with previous reports in HFD-fed mice [8], db/db mice [71] and subjects with T2D [10].”
BackgroundResultInfluentialResearch progress of diabetic retinopathy and gut microecology
Wang, R., Wang, Q., Bai, Y., Bi, Y.-G., & Cai, S.-J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1256878 · Cited by 17
Gut microb-aging and its relevance to frailty aging
Cosquer, G. L., Vergnolle, N., & Motta, J. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105309 · Cited by 16
Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer
Yu, Y., Li, L., Yang, Q., Xue, J., Wang, B., Xie, M., Shangguan, W., Zhu, Z., & Wu, P. (2024) · Microorganisms · doi:10.3390/microorganisms12081653 · Cited by 16
“AKK has been widely reported to protect the intestinal barrier by secreting short-chain fatty acids [40–42].”
BackgroundThe AMPK/GDF15 Axis: A Novel Target for the Neuroprotective Effects of Metformin in Ischemic Stroke
Alshehri, G. H., Al-Kuraishy, H. M., Alsfouk, B. A. A., Al-Gareeb, A. I., Faheem, S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05126-7 · Cited by 16
“It has been shown that metformin activates the release of the short-chain fatty acids (SCFAs) from gut microbiota that induce the expression of the GLP1 gene in the enteroendocrine L cells with subsequent release of GLP1 hormone [41].”
Simopoulos, C. M. A., Ning, Z., Zhang, X., Li, L., Walker, K., Lavallée‐Adam, M., & Figeys, D. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa289 · Cited by 16
Oat β Glucan Ameliorates Renal Function and Gut Microbiota in Diabetic Rats
Wang, R., Zhang, Z., Aihemaitijiang, S., Ye, C., Halimulati, M., Huang, X., & Qin, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.875060 · Cited by 24
Yang, Y., Su, W., Zang, C., Tan, Y., Zhang, Y., Zhou, Z., Lu, W., Wu, S., Zhang, X., & Wu, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116256 · Cited by 17
Bacteria in the ageing gut: did the taming of fire promote a long human lifespan?
Danchin, A. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14255 · Cited by 16
Ortega-Vega, E. L., Guzmán-Castañeda, S. J., Campo, O., Velásquez-Mejía, E. P., de la Cuesta‐Zuluaga, J., Bedoya, G., & Escobar, J. S. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1619440 · Cited by 18
“The former species was included in a mix of 17 bacterial strains that enhanced immune regulatory T cells and induced anti-inflammatory molecules upon inoculation in germ-free mice(33) while the latter was more abundant in non-diabetic individuals than diabetic patients under metformin treatment.(34) The genus Clostrid…”
BackgroundSelf-citationMetformin action in the gut―insight provided by [18F]FDG PET imaging
Tsuchida, H., Morita, Y., Nogami, M., & Ogawa, W. (2021) · Diabetology International · doi:10.1007/s13340-021-00545-y · Cited by 16
Guo, Y., Zhang, N., & Pei, D. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1645298 · Cited by 18
Metformin—mechanisms of its glycemia-reducing effect
Drewe, J., Foretz, M., & Krähenbühl, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100106 · Cited by 19
Tassoulas, L. J., & Wackett, L. P. (2024) · iScience · doi:10.1016/j.isci.2024.108900 · Cited by 17
“3,6,49 In the aforementioned study by Kitada et al., the addition of SCFA-producing Bifidobacterium microbes in co-culture with E. coli and Enterococcus faecalis led to an acidification of the medium and increased putrescine production, from E. coli and Enterococcus , more than 2-fold.”
BackgroundGut aging: A wane from the normal to repercussion and gerotherapeutic strategies
Abankwah, J. K., Wang, Y., Wang, J., Enechojo, O. S., Pozzo, L. D., Chu, X., & Bian, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37883 · Cited by 19
“Metformin (biguanide with 50% bioavailability via oral route) is the most prescribed drug for the treatment of type-2 diabetes but is currently repurposed to serve as a gerotherapeutic drug [121,122].”
BackgroundGastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
Borg, M. J., Rayner, C. K., Jones, K. L., Horowitz, M., Xie, C., & Wu, T. (2020) · Pharmaceuticals · doi:10.3390/ph13110410 · Cited by 17
“, bacteria with contrasting DNA, but below the threshold of genetic variability is to be classed as a separate species [51].”
BackgroundA diet high in FODMAPs as a novel dietary strategy in diabetes?
Chu, N. H. S., Chan, J. C. N., & Chow, E. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.036 · Cited by 15
Cheng, W., Cai, C., Kreft, I., Turnšek, T. L., Zu, M., Hu, Y., Zhou, M., & Liao, Z. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4524444 · Cited by 16
“Akkermansia is a mucin-degrading bacterium and can improve insulin resistance [52].”
Kusunoki, M., Hisano, F., Matsuda, S., Kusunoki, A., Wakazono, N., Tsutsumi, K., & Miyata, T. (2023) · Drug Research · doi:10.1055/a-2037-5250 · Cited by 16
“reported that shortchain fatty acid producing bacteria, which produce intestinal shortchain fatty acids (acetic acid, lactic acid, propionic acid), are less abundant in patients with type 2 diabetes mellitus, and that administration of metformin increased the populations of Akkermansia muciniphila and Bifidobacteri…”
BackgroundEl-Komy, M. H. M., Abdo, N. M. K., Shamma, R. N., & Bedair, N. I. (2023) · Experimental Dermatology · doi:10.1111/exd.14868 · Cited by 15
Asperlin Stimulates Energy Expenditure and Modulates Gut Microbiota in HFD-Fed Mice
Wu, C., Zhou, Y., Qi, G., Liu, D., Cao, X., Yu, J., Zhang, R., Lin, W., & Guo, P. (2019) · Marine Drugs · doi:10.3390/md17010038 · Cited by 15
“Many natural products such as metformin [12,13], cranberry [14] and ganoderma [15] extracts have been reported to exert their pharmacological properties through modulation of gut microbiota.”
BackgroundItoh, H., & Tanaka, M. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100169 · Cited by 16
“Metformin shifted gut microbiota composition and increased several SCFA-producing microbiotas [59].”
BackgroundA blast from the past: To tame time with metformin
Xenos, D., Mecocci, P., & Boccardi, V. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111743 · Cited by 16
Nallappan, D., Chua, K. H., Ong, K. C., Chong, C. W., Teh, C. S. J., Palanisamy, U. D., & Kuppusamy, U. R. (2021) · Food & Function · doi:10.1039/d1fo00539a · Cited by 16
Yang, R., Liu, J., Diao, L., Wei, L., Luo, H., & Cai, L. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.01.023 · Cited by 14
Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology
Shivaprakash, P., Beeraka, N. M., Madhunapantula, S. V., Nikolenko, V. N., & Basalingappa, K. M. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673289342240213040144 · Cited by 15
Hsiao, Y.-K., Lee, B., & Wu, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1305617 · Cited by 14
Mruk-Mazurkiewicz, H., Kulaszyńska, M., Jakubczyk, K., Janda, K., Czarnecka, W., Rębacz‐Maron, E., Zacha, S., Sieńko, J., Zeair, S., Dalewski, B., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030952 · Cited by 17
Striking a gut–liver balance for the antidiabetic effects of metformin
Barroso, E., Montori-Grau, M., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.04.004 · Cited by 15
Choe, S., Lee, J., Park, J. W., Jeong, S., Cho, Y. M., Park, B., & Shin, A. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1455 · Cited by 14
“Another explanation is that these effects are mainly caused by the anticancer effect of metformin, which has been well elucidated in many other studies (11, 22, 23, 25), including the effect of metformin associated with the abundance of Akkermansia muciniphila in the colon that directly enhances metabolism and improve…”
BackgroundLi, L., Huang, G., Chen, T.-B., Lin, H. M., Xu, R., Cheng, J., Hu, Y., Dai, W., & Dong, G. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3255401 · Cited by 15
Zhang, M., Wei, J., Sun, Y., He, C., Ma, S., Pan, X., & Zhu, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.008 · Cited by 16
Kim, H.-B., Cho, Y., & Choi, S. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-72467-z · Cited by 14
“However, A. mucin-iphila, a bacterium well-known for its beneficial effects , did not show significant changes with metformin intake, contrary to previous reports 6,7 .”
ResultBalancing act: counteracting adverse drug effects on the microbiome
de la Cuesta‐Zuluaga, J., Müller, P., & Maier, L. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.09.011 · Cited by 13
Chew, G. M., Padua, A. J., Chow, D. C., Souza, S. A., Clements, D. M., Corley, M. J., Pang, A. P. S., Alejandria, M. M., Gerschenson, M., Shikuma, C. M., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0172 · Cited by 13
“Metformin alters the gut microbiome by increasing mucin-degrading Akkermansia muciniphila along with several butyrate-producing bacteria, contributing to intestinal tract integrity reducing inflammation.(29,30) Moreover, gut microbiome profile has been implicated in the positive outcomes of cancer individuals receivin…”
BackgroundGeng, Y., Wang, Z., Xu, X., Sun, X., Dong, X., Luo, Y., & Sun, X. (2023) · Translational research · doi:10.1016/j.trsl.2023.08.001 · Cited by 15
Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology
Li, X., Shen, L., & Ji, H. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s203239 · Cited by 13
“Previous studies also found increased relative abundance of Bifidobacterium in T2D patients after treatment with metformin.(26,27) Although no metabolic pathway associated with differential bacteria was found in functional prediction analysis, the biosynthesis processes of bacteria was increased in the astragalus grou…”
ResultSystems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response
Kirtipal, N., Seo, Y. D., Son, J. W., & Lee, S. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0382 · Cited by 12
A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory
Yang, W., Cui, H., Wang, C., Wang, X., Yan, C., & Cheng, W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1454780 · Cited by 18
Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics
Tariq, H. M. A., Khan, N. Y., Manzoor, H., & Kayani, M. U. R. (2025) · Discover Medicine · doi:10.1007/s44337-025-00241-9 · Cited by 12
“Rodent supplementation with oligo-fructose or direct treatment with Akkermansia results in improved metabolic status [55].”
Fatahi, S., Sohouli, M. H., Vahidshahi, K., Rohani, P., Safa, M., Salehi, M., Găman, M., & Shidfar, F. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01681-0 · Cited by 14
The role of intestinal microbiota and its metabolites in the occurrence and intervention of obesity
Gao, Y., Liu, W., Ma, X., Xue, M., Li, Y., Bi, S., & Leng, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1559178 · Cited by 15
Godet, M., Meugnier, E., Vitalis, O., Bendridi, N., Vieille‐Marchiset, A., Véga, N., Benoit, B., Pinteur, C., Rainteau, D. P., Cheillan, D., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102263 · Cited by 13
“Several studies report significant metabolome changes following metformin in bio-fluids and tissue [23], including increased production of short-chain fatty acids (SCFAs) by gut microbiota, as observed in clinical trials [24,25].”
InfluentialMudali, D., Jeevanandam, J., & Danquah, M. K. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1789062 · Cited by 12
Wu, H., Wang, X., Fang, X., Lian, F., Li, M., Liao, J., Dai, D., & Tian, J. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003149 · Cited by 14
Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
Alfaraidi, H., & Samaan, M. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1072879 · Cited by 13
“Furthermore, Metformin influences the gut microbiome by promoting the growth of beneficial species that degrade mucin and generate short-chain fatty acids (91, 92).”
BackgroundLicata, A., Russo, G. T., Giandalia, A., Cammilleri, M., Asero, C., & Cacciola, I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030558 · Cited by 14
Morrice, N., Vainio, S., Mikkola, K., van Aalten, L., Gallagher, J. R., Ashford, M. L. J., McNeilly, A. D., McCrimmon, R. J., Grosfeld, A., Serradas, P., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101807 · Cited by 16
Hung, W., Peng, P., Tsai, Y., Jhou, P.-S., Chang, C.-C., Hsieh, C.-C., Su, Y., Dai, C., & Hung, W. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108731 · Cited by 13
Burnham, C. M., McKenney, E. A., Heugten, K. A., Minter, L. J., & Trivedi, S. (2023) · Animal Microbiome · doi:10.1186/s42523-023-00249-5 · Cited by 12
Bringing pharmacomicrobiomics to the clinic through well‐designed studies
Steiner, H. E., Patterson, H. K., Giles, J. B., & Karnes, J. H. (2022) · Clinical and Translational Science · doi:10.1111/cts.13381 · Cited by 12
The Human Microbiome as a Therapeutic Target for Metabolic Diseases
Bui, T. P. N. (2024) · Nutrients · doi:10.3390/nu16142322 · Cited by 12
“Furthermore, metformin has been reported to increase the relative abundance of A. muciniphila in vitro and in humans [44,70], supporting a protective role of this bacterium in metabolic disorders.”
BackgroundRui, L., & Chen, R. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2385065 · Cited by 12
“Previous investigations primarily explored the relationship between these factors through clinical trials and animal models [19,20].”
BackgroundAndrei, C., Zanfirescu, A., Ormeneanu, V.-P., & Negreș, S. (2025) · Antibiotics · doi:10.3390/antibiotics14020138 · Cited by 13
Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes
Aljumaah, M. R., Roach, J. M., Hu, Y., Gunstad, J., & Azcárate-Peril, M. A. (2025) · Science Advances · doi:10.1126/sciadv.ads5721 · Cited by 13
The microbial revolution: Akkermansia muciniphila's role in overcoming immunotherapy challenges
Shi, Y., Fu, Y., & Tang, D. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115374 · Cited by 11
Intriguing Role of Gut-Brain Axis on Cognition with an Emphasis on Interaction with Papez Circuit
Xavier, J., Anu, M., Fathima, A. S., Ravichandiran, V., & Kumar, N. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220614124145 · Cited by 11
Petakh, P., Kamyshna, I. I., & Kamyshnyi, O. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1260633 · Cited by 12
Zhou, Y., Zhang, L., Guo, F., Liu, X., Li, X., Han, Z., Li, X., Shi, X., Wen, L., & Wang, J. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300398 · Cited by 13
Ismail, H. M., & Evans‐Molina, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.892291 · Cited by 12
Temporary consumption of western diet trains the immune system to reduce future gut inflammation
Wu, D., Wang, X., Yang, X., Gu, L., McGeachy, M. J., & Liu, X. (2023) · iScience · doi:10.1016/j.isci.2023.106915 · Cited by 12
Tseng, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739141 · Cited by 11
The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2
Pokrovskaya, E. V., Шамхалова, М. Ш., & Shestakova, M. V. (2019) · Diabetes Mellitus · doi:10.14341/dm10194 · Cited by 15
Allin, K. H., Jensen, C. B., Jacobsen, R. K., & Jess, T. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01896-2 · Cited by 10
Xiong, L., Huang, Y.-X., Mao, L., Xu, Y., & Deng, Y. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.98788 · Cited by 10
Parascinet, O., Mas, S., Hang, T., Llavero, C., Lorenzo, Ó., & Ruíz-Tóvar, J. (2023) · Nutrients · doi:10.3390/nu15051067 · Cited by 10
“muciniphila has been described as a mucin-degrading bacteria with protective roles on intestinal gut barrier [39,40].”
BackgroundPeng, X., Chen, S., Zhong, L. X., Li, Y., Wu, C., Zhong, L., Chen, W., Yang, J., Zeng, J., & Tang, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176256 · Cited by 10
Liu, X., Du, P., Xu, J., Wang, W., & Zhang, C. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s474196 · Cited by 11
How gut microbiota relate to the oral antidiabetic treatment of type 2 diabetes
Hung, W., & Hung, W.-C. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100007 · Cited by 11
Liang, J., Cai, Y., Zhang, J., Jing, Z., Lv, L., Zhang, G., Zhang, R., Liu, R., Nan, K., & Dang, X. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072461 · Cited by 13
Qiao, Z., Han, J., Feng, H., Zheng, H., Wu, J., Gao, C., Yang, M., You, C., Liu, Z., & Wu, Z. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03292 · Cited by 10
Checkpoints Under Traffic Control: From and to Organelles
Deng, S., Zhou, X., & Xu, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_18 · Cited by 10
Tao, W., Yu, Y., Tan, D., Huang, X., Huang, J., Lin, C., & Yu, R. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1603442 · Cited by 9
Akkermansia muciniphila inhibits jejunal lipid absorption and regulates jejunal core bacteria
Ma, Q., Zhou, X., Su, W., Wang, Q., Yu, G., Tao, W., Dong, Z., Wang, C., Wong, C.-M., Liu, T., et al. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128053 · Cited by 10
Sala, L. L., Carlini, V., Macas-Granizo, M. B., Trabucchi, E., Pontiroli, A. E., Berra, C., Naselli, A., D’Anzeo, M., Porta, A., Martín-Delgado, J., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.021 · Cited by 9
Beyond diabetes: harnessing the power of metformin in burn care
Khalaf, F., Touma, D., Saldanha, S., Khalaf, G., Barayan, D., & Jeschke, M. G. (2025) · Critical Care · doi:10.1186/s13054-025-05662-7 · Cited by 9
Ikarashi, N., Kon, R., Sakai, H., & Hosoe, T. (2025) · Journal of Natural Medicines · doi:10.1007/s11418-025-01959-7 · Cited by 9
“The composition and function of the gut microbiota are known to be influenced by drugs, such as antibiotics [50, 51], dietary habits [52–54], and aging [55].”
Metadata
- Authors
- de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S.
- Affiliations
- Vidarium—Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia
- Johns Hopkins University (US)
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica I.P.S.—Especialista en Ayudas Diagnósticas, Medellin, Colombia
- EPS y Medicina Prepagada Suramericana S.A., Medellin, Colombia
- Corresponding author
- Escobar, Juan S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-14
- Volume
- 40
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553515186
- Cited by
- 704
- References
- 40
- Citations by year
- 2026: 55 · 2025: 69 · 2024: 86 · 2023: 80 · 2022: 106 · 2021: 78 · 2020: 87 · 2019: 62 · 2018: 45 · 2017: 33 · 2016: 1
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- metformin, Akkermansia muciniphila, gut microbiota, short-chain fatty acids, type 2 diabetes, mucin degradation, Butyrivibrio, Bifidobacterium bifidum, Megasphaera, Prevotella, Clostridiaceae, Enterococcus casseliflavus, fecal microbiota composition, glycemic control
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Colombia, Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Feces, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Mucins, RNA, Ribosomal, 16S, Case-Control Studies, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.